EMEA-002414-PIP01-18 - paediatric investigation plan
Humanized anti-CD19, Fc engineered, monoclonal antibody (XmAb5871)
PIPHuman
P/0274/2019: EMA decision of 16 August 2019 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for humanized anti-CD19, Fc engineered, monoclonal antibody (XmAb5871) (EMEA-002414-PIP01-18)